PROCESSA PHARMACEUTICALS INC (PCSA) Stock Balance Sheet
NASDAQ:PCSA • US74275C4033
Current stock price
2.33 USD
-0.02 (-0.85%)
At close:
2.1692 USD
-0.16 (-6.9%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 5.54M | 1.19M | 4.71M | 6.50M | 16.50M | |||
| Receivables | N/A | N/A | N/A | N/A | 70.00K | |||
| Other Current Assets | 133.90K | 682.30K | 926.00K | 1.88M | 1.76M | |||
| Total Current Assets | 5.67M | 1.87M | 5.63M | 8.39M | 18.33M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.80K | 75.70K | 149.00K | 228.00K | 74.00K | |||
| Investments And Advances | 1.15M | N/A | N/A | N/A | N/A | |||
| Intangibles | N/A | N/A | N/A | 0.00 | 8.06M | |||
| Other Non-Current Assets | 993.70K | 1.28M | 6.00K | 6.00K | 6.00K | |||
| Total Non-Current Assets | 2.14M | 1.36M | 154.00K | 233.00K | 8.14M | |||
| TOTAL ASSETS | 7.81M | 3.23M | 5.79M | 8.62M | 26.46M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 6.10K | N/A | N/A | 0.00 | |||
| Accrued Expenses | 1.18M | 645.60K | 230.00K | 482.00K | 350.00K | |||
| Accounts Payable | 1.06M | 880.90K | 312.00K | 328.00K | 219.00K | |||
| Other Current Liabilities | N/A | N/A | 189.00K | 189.00K | 402.00K | |||
| Total Current Liabilities | 2.24M | 1.53M | 731.00K | 999.00K | 971.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 500.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Liabilities | N/A | 0.00 | 67.00K | 151.00K | 7.00K | |||
| Total Non-Current Liabilities | 0.00 | 500.00 | 66.00K | 150.00K | 7.00K | |||
| TOTAL LIABILITIES | 2.24M | 1.53M | 797.00K | 1.15M | 978.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -100.78M | -87.22M | -75.37M | -64.25M | -36.82M | |||
| Additional Paid In Capital | 106.66M | 89.22M | 80.66M | 72.02M | 62.31M | |||
| Common Shares | 300.00 | 400.00 | 0.00 | 2.00K | 2.00K | |||
| Treasury Stock | -300.00K | -300.00K | -300.00K | -300.00K | N/A | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 2.57M | 148.10K | 51.40K | 32.10K | 31.40K | |||
| Tangible Book Value per Share | 2.17 | 11.45 | 3.88 | 9.32 | 554.68 | |||
| Total Shareholders' Equity | 5.58M | 1.70M | 4.99M | 7.47M | 25.48M | |||
| TOTAL LIABILITIES AND EQUITY | 7.81M | 3.23M | 5.79M | 8.62M | 26.46M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.00 | N/A | N/A | N/A | |||
| Current Ratio | 2.54 | 1.22 | 7.71 | 8.40 | 18.87 | |||
| Return On Assets (ROA) | -173.59% | -366.96% | -192.18% | -318.15% | -43.18% | |||
| Return On Equity (ROE) | -243.20% | -698.63% | -222.92% | -367.08% | -44.84% | |||
All data in USD , ROIC based on taxRate of 0.21